$AMOD
ALPHA MODUS HOLDINGS, INC.

2023 Q3 Form 10-Q Financial Statement

#000121390023087203 Filed on November 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $525.4K
YoY Change 88.73%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.411M
YoY Change 329.89%
Operating Profit -$575.4K
YoY Change 75.29%
Interest Expense $391.5K
YoY Change -86.78%
% of Operating Profit
Other Income/Expense, Net $399.5K
YoY Change -86.51%
Pretax Income -$175.9K
YoY Change -106.68%
Income Tax $51.73K
% Of Pretax Income
Net Earnings -$227.6K
YoY Change -109.52%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $392.3K
YoY Change -23.97%
Inventory
Prepaid Expenses $86.17K
Receivables
Other Receivables
Total Short-Term Assets $1.433M
YoY Change 86.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.43M
YoY Change -95.7%
Other Assets
YoY Change
Total Long-Term Assets $10.43M
YoY Change -95.7%
TOTAL ASSETS
Total Short-Term Assets $1.433M
Total Long-Term Assets $10.43M
Total Assets $11.86M
YoY Change -95.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.06K
YoY Change -68.03%
Accrued Expenses $518.0K
YoY Change 659.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.626M
YoY Change 710.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $7.274M
YoY Change -48.3%
Total Long-Term Liabilities $7.274M
YoY Change -48.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.626M
Total Long-Term Liabilities $7.274M
Total Liabilities $11.90M
YoY Change -18.72%
SHAREHOLDERS EQUITY
Retained Earnings -$11.26M
YoY Change -16.19%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$11.26M
YoY Change
Total Liabilities & Shareholders Equity $11.86M
YoY Change -95.12%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$227.6K
YoY Change -109.52%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.407M
YoY Change 1684.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $19.80M
YoY Change 9518.38%
Cash From Investing Activities $19.80M
YoY Change 9518.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.79M
YoY Change
NET CHANGE
Cash From Operating Activities -1.407M
Cash From Investing Activities 19.80M
Cash From Financing Activities -18.79M
Net Change In Cash -396.0K
YoY Change -411.74%
FREE CASH FLOW
Cash From Operating Activities -$1.407M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-40775
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3386030
dei Entity Address Address Line1
EntityAddressAddressLine1
333 East 91st Street
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10128
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
374-2922
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171583 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
306096 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
86173 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
367219 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1433269 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
538802 usd
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
10426124 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
244314622 usd
CY2023Q3 us-gaap Assets
Assets
11859393 usd
CY2022Q4 us-gaap Assets
Assets
244853424 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
51055 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
128835 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
518002 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68216 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
150000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
671759 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
467991 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2348302 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
157200 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
149041 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4626318 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
899083 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
156593 usd
CY2023Q3 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
6600000 usd
CY2022Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000 usd
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
673805 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
84890 usd
CY2023Q3 us-gaap Liabilities
Liabilities
11900123 usd
CY2022Q4 us-gaap Liabilities
Liabilities
13140566 usd
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
11221524 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
243597590 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11262854 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11885332 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-11262254 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11884732 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11859393 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244853424 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
450375 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
278380 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1372947 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1030966 usd
CY2023Q3 us-gaap Franchisor Costs
FranchisorCosts
50000 usd
CY2022Q3 us-gaap Franchisor Costs
FranchisorCosts
49863 usd
us-gaap Franchisor Costs
FranchisorCosts
150000 usd
us-gaap Franchisor Costs
FranchisorCosts
147995 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-575375 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-328243 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1747947 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1178961 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7245 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1790500 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
588915 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8726170 usd
CY2023Q3 inaq Change In Fair Value Of Forward Purchases Agreement Liability
ChangeInFairValueOfForwardPurchasesAgreementLiability
8035 usd
inaq Change In Fair Value Of Forward Purchases Agreement Liability
ChangeInFairValueOfForwardPurchasesAgreementLiability
86369 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
384239 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1170566 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2898987 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1299387 usd
inaq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
273110 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
399519 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2961066 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2669551 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10025557 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-175856 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2632823 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
921604 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8846596 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51725 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
241792 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
637175 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
241792 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-227581 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2391031 usd
us-gaap Net Income Loss
NetIncomeLoss
284429 usd
us-gaap Net Income Loss
NetIncomeLoss
8604804 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11884732 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3628151 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
100000 usd
CY2023Q1 inaq Stock Issue During Period Value Initial Value Of Forward Purchased Agreement
StockIssueDuringPeriodValueInitialValueOfForwardPurchasedAgreement
-86369 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
895469 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7347481 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-253965 usd
CY2023Q2 inaq Stock Issued During Period Value Excise Tax Payable
StockIssuedDuringPeriodValueExciseTaxPayable
-2156214 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-383459 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-10141119 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-701466 usd
CY2023Q3 inaq Stock Issued During Period Value Excise Tax Payable
StockIssuedDuringPeriodValueExciseTaxPayable
-192088 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-227581 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-11262254 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3379497 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-18015079 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2834276 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-15180803 usd
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-648626 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2391031 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-13438398 usd
us-gaap Net Income Loss
NetIncomeLoss
284429 usd
us-gaap Net Income Loss
NetIncomeLoss
8604804 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
588915 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8726170 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
2898986 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
1299387 usd
inaq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
273110 usd
inaq Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability
GainLossChangeInFairValueOfForwardPurchaseAgreementLiability
86369 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-156593 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-281046 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-360348 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-77780 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
125353 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
449786 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-2746 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
225000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
891000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
203768 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
241792 usd
inaq Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-8159 usd
inaq Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
49230 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2342735 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-745236 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
inaq Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
2457248 usd
inaq Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
205853 usd
inaq Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
234830236 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
236787484 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
205853 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
100000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
420000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
85000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
234830236 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-234310236 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
134513 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-624383 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171583 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877937 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
306096 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
253554 usd
CY2022Q3 us-gaap Cash
Cash
253554 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
306096 usd
inaq Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
5126890 usd
inaq Value Of Excise Tax Liability
ValueOfExciseTaxLiability
2348302 usd
inaq Increase In Due To Investor
IncreaseInDueToInvestor
150000 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-04-20
inaq Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
P185D
CY2023Q3 inaq Percentage Of Aggregate Fair Market Value Of Asset
PercentageOfAggregateFairMarketValueOfAsset
0.80 pure
inaq Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum
BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum
0.50 pure
CY2023Q3 inaq Percentage Of Shares Voted
PercentageOfSharesVoted
0.65 pure
CY2024Q2 inaq Interest Used To Pay Dissolution Expenses Maximum
InterestUsedToPayDissolutionExpensesMaximum
100000 usd
CY2023Q3 inaq Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001 usd
CY2023Q1 inaq Business Combination Date Of Consummation
BusinessCombinationDateOfConsummation
2023-05-07
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
80000 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
300000 usd
inaq Avila Payment Description
AvilaPaymentDescription
1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023Q3 us-gaap Advance Royalties
AdvanceRoyalties
480000 usd
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1
CY2023Q3 us-gaap Deposits
Deposits
20000 usd
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
1847662 shares
CY2023Q3 inaq Total Redemption Payment
TotalRedemptionPayment
19208848 usd
CY2023Q3 us-gaap Deposits
Deposits
20000 usd
CY2023Q3 us-gaap Share Price
SharePrice
10.05
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
CY2023Q1 inaq Total Redemption Payment
TotalRedemptionPayment
215621387 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2348302 usd
inaq Percentage Of Excise Tax
PercentageOfExciseTax
0.01 pure
us-gaap Operating Expenses
OperatingExpenses
0 usd
CY2023Q3 inaq Working Capital Deficit
WorkingCapitalDeficit
3193049 usd
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
163000 usd
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
157000 usd
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6000 usd
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
480000 usd
CY2023Q3 inaq Sponsor Advance
SponsorAdvance
480000 usd
CY2023Q3 inaq Price Per Units
PricePerUnits
1
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
306096 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
CY2023Q3 us-gaap Fair Value Concentration Of Risk Guarantees
FairValueConcentrationOfRiskGuarantees
250000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
inaq Maturity Days
MaturityDays
P185Y
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
156593 usd
CY2023Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
52000 usd
CY2022Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
242000 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
637000 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
242000 usd
CY2023Q1 inaq Waiver Of Underwriting Commissions
WaiverOfUnderwritingCommissions
5400000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
usd
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
the Company effected a 1:1.1162791 stock split of Class B common stock
CY2023Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
30000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
90000 usd
CY2023Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
480000 usd
CY2023Q3 inaq Sponsor Advance
SponsorAdvance
480000 usd
CY2023Q3 inaq Price Per Units
PricePerUnits
1
CY2023Q3 us-gaap Advance Royalties
AdvanceRoyalties
420000 usd
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
400000 usd
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
80000 usd
CY2023Q1 inaq Outstanding Per Share
OutstandingPerShare
0.04
CY2023Q1 inaq Extension Deposited
ExtensionDeposited
20000 usd
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
20000 usd
CY2023Q3 inaq Outstanding Per Share
OutstandingPerShare
0.02
CY2023Q3 inaq Due To Related Party
DueToRelatedParty
420000 usd
CY2022Q4 inaq Due To Related Party
DueToRelatedParty
0 usd
inaq Due From Related Party Descriptin
DueFromRelatedPartyDescriptin
On July 20, 2023 and August 7, 2023, a total of $891,000 was transferred to the Sponsor from the operating bank account and $150,000 is due from the Sponsor related to the subscription agreement as noted in Note 6, of which a total of $891,000 was paid back on October 10, 2023, October 11, 2023 and November 2, 2023.
CY2023Q3 inaq Due From Related Party
DueFromRelatedParty
1041000 usd
CY2022Q4 inaq Due From Related Party
DueFromRelatedParty
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
usd
CY2023Q1 inaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
8400000 usd
CY2023Q1 inaq Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable
GainLossOnForgivenessOfDeferredUnderwritingFeesPayable
273110 usd
CY2023Q1 inaq Reminder Of Deferred Underwriting Commissions
ReminderOfDeferredUnderwritingCommissions
3000000 usd
CY2023Q3 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
6600000 usd
CY2022Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000 usd
CY2023Q3 inaq Reimbursement Of Expenses
ReimbursementOfExpenses
300000 usd
inaq Avila Payment Description
AvilaPaymentDescription
1) up to $300,000 immediately upon Avila’s receipt of net proceeds from any financing, public or private, in excess of U.S. $3,000,000, -or- (2) (i) $50,000 by December 1, 2023, (ii) $100,000 by February 1, 2024 and (iii) $150,000 by April 1, 2024.
CY2023Q3 us-gaap Sponsor Fees
SponsorFees
1000000 usd
CY2023Q3 inaq Polar Funded Sponsor
PolarFundedSponsor
150000 usd
CY2023Q3 inaq Sponsor Loaned
SponsorLoaned
150000 usd
CY2023Q3 inaq Issuance Share
issuanceShare
1 shares
CY2023Q3 us-gaap Capital Units Outstanding
CapitalUnitsOutstanding
10 shares
CY2023Q3 inaq Reasonable Attorneys Fees
ReasonableAttorneysFees
5000 usd
inaq Sponsor Descriptiom
SponsorDescriptiom
then the Sponsor shall be required to transfer to Polar 0.1 share of Class A Common Stock or Class B Common Stock for each $1 that Polar has funded under the Capital Calls as of the date of such Default and shall be required repeat such issuance for each month the such Default continues.
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
1847662 shares
CY2023Q3 inaq Percentage Of Common Stock Holding
PercentageOfCommonStockHolding
0.65 pure
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1000945 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
6100945 shares
us-gaap Business Acquisition Planned Restructuring Activities Description
BusinessAcquisitionPlannedRestructuringActivitiesDescription
if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Stockholders or their affiliates, without taking into account any Founder Shares held by the Initial Stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
us-gaap Class Of Warrant Or Right Expense Or Revenue Recognized
ClassOfWarrantOrRightExpenseOrRevenueRecognized
Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants): ●in whole and not in part; ●at a price of $0.01 per warrant; ●upon a minimum of 30 days’ prior written notice of redemption; and ●if, and only if, the closing price of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
CY2023Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
7000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
589000 usd
CY2022Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
1800000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
8700000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
891000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
891000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q3 inaq Change In Fair Value Of Forward Purchases Agreement Liability
ChangeInFairValueOfForwardPurchasesAgreementLiability
usd
inaq Change In Fair Value Of Forward Purchases Agreement Liability
ChangeInFairValueOfForwardPurchasesAgreementLiability
usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
inaq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
usd
inaq Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability
GainLossChangeInFairValueOfForwardPurchaseAgreementLiability
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
usd
inaq Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
usd
inaq Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
usd
inaq Value Of Excise Tax Liability
ValueOfExciseTaxLiability
usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
usd
us-gaap Common Stock Voting Rights
CommonStockVotingRights
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001862463

Files In Submission

Name View Source Status
0001213900-23-087203-index-headers.html Edgar Link pending
0001213900-23-087203-index.html Edgar Link pending
0001213900-23-087203.txt Edgar Link pending
0001213900-23-087203-xbrl.zip Edgar Link pending
f10q0923ex31-1_insightacq.htm Edgar Link pending
f10q0923ex31-2_insightacq.htm Edgar Link pending
f10q0923ex32-1_insightacq.htm Edgar Link pending
f10q0923ex32-2_insightacq.htm Edgar Link pending
f10q0923_insightacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inaq-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inaq-20230930_cal.xml Edgar Link unprocessable
inaq-20230930_def.xml Edgar Link unprocessable
inaq-20230930_pre.xml Edgar Link unprocessable
inaq-20230930_lab.xml Edgar Link unprocessable
f10q0923_insightacq_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending